Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.1B | 7.0B | 6.9B | 7.0B |
Cost of revenue | 3.3B | 3.2B | 3.1B | 3.2B |
Gross profit | 3.8B | 3.8B | 3.8B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.7B | 1.7B | 1.8B | 1.6B |
Operating income | 1.0B | 999.5M | 1.1B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 25.0M | 21.0M | 22.9M | 24.6M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.2B | 1.3B | 1.3B |
Tax provision | 300.6M | 281.8M | 304.2M | 320.4M |
Net income | 928.4M | 879.7M | 970.9M | 933.7M |
Basic EPS | — | 7.8 | 8.7 | 8.4 |
Diluted EPS | — | 7.8 | 8.7 | 8.4 |
Basic average shares | — | 110.7M | 110.7M | 110.7M |
Diluted average shares | — | 110.7M | 110.7M | 110.7M |
EBITDA | 1.5B | 1.4B | 1.5B | 1.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.0M | -11.5M | -9.1M | -1.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |